Literature DB >> 27540322

Genotypic Detection of rpoB and katG Gene Mutations Associated with Rifampicin and Isoniazid Resistance in Mycobacterium Tuberculosis Isolates: A Local Scenario (Kelantan).

Nurul-Ain Ismail1, Mohd Fazli Ismail2, Siti Suraiya Md Noor2, Siti Nazrina Camalxaman1.   

Abstract

BACKGROUND: Drug resistant tuberculosis (DR-TB) remains a public health issue that is of major concern on a global scale. The characterisation of clinical isolates may provide key information regarding the underlying mechanisms of drug resistance, and helps to augment therapeutic options. This study aims to evaluate the frequency of gene mutations associated with Rifampicin (RIF) and Isoniazid (INH) resistance among nine clinical isolates.
METHODS: A total of nine drug resistant Mycobacterium tuberculosis clinical isolates were screened for genetic mutations in rpoB and katusing polymerase chain reaction (PCR) amplification and DNA sequencing. Genotypic analysis was performed to detect the mutations in the sequence of the target genes.
RESULTS: Our findings reveal that 80% of the isolates possess mutations at codon 119 (His119Tyr) and 135 (Arg135Trp and Ser135Leu) within the rpoB gene; and 70% possess mutations in the katG gene at codon 238 with amino acid change (Leu238Arg).
CONCLUSION: Findings from this study provide an overview of the current situation of RIF and INH resistance in a hospital Universiti Sains Malaysia (HUSM) located in Kelantan, Malaysia, which could facilitate molecular-based detection methods of drug-resistant strains. Further information regarding the molecular mechanisms involved in resistance in RR-/MDR-TB should be addressed in the near future.

Entities:  

Keywords:  M. tuberculosis; isoniazid; katG; mutation; rifampicin; rpoB

Year:  2016        PMID: 27540322      PMCID: PMC4975585     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  16 in total

1.  Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.

Authors:  Lina Marcela Aragón; Ferran Navarro; Volker Heiser; Montserrat Garrigó; Montserrat Español; Pere Coll
Journal:  J Antimicrob Chemother       Date:  2006-03-17       Impact factor: 5.790

2.  Mutations in rpoB and katG genes in Mycobacterium isolates from the Southeast of Mexico.

Authors:  R Zenteno-Cuevas; J C Zenteno; A Cuellar; B Cuevas; C L Sampieri; J E Riviera; A Parissi
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-05       Impact factor: 2.743

3.  Tuberculosis, drug resistance, and the history of modern medicine.

Authors:  Salmaan Keshavjee; Paul E Farmer
Journal:  N Engl J Med       Date:  2012-09-06       Impact factor: 91.245

Review 4.  Role of individual drugs in the chemotherapy of tuberculosis.

Authors:  D A Mitchison
Journal:  Int J Tuberc Lung Dis       Date:  2000-09       Impact factor: 2.373

5.  Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.

Authors:  Håvard Valvatne; Heidi Syre; Martijn Kross; Ruth Stavrum; Ti Ti; Sabai Phyu; Harleen M S Grewal
Journal:  J Antimicrob Chemother       Date:  2009-08-26       Impact factor: 5.790

6.  Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda.

Authors:  Beth Temple; Irene Ayakaka; Sam Ogwang; Helen Nabanjja; Susan Kayes; Susan Nakubulwa; William Worodria; Jonathan Levin; Moses Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Peter G Smith; Roy D Mugerwa; Jerrold J Ellner; Edward C Jones-López
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

7.  Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.

Authors:  Belay Tessema; Joerg Beer; Frank Emmrich; Ulrich Sack; Arne C Rodloff
Journal:  BMC Infect Dis       Date:  2012-02-10       Impact factor: 3.090

Review 8.  The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Authors:  A Somoskovi; L M Parsons; M Salfinger
Journal:  Respir Res       Date:  2001-04-05

9.  Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.

Authors:  Amina Abdelaal; Hassan Abd El-Ghaffar; Mohammad Hosam Eldeen Zaghloul; Noha El Mashad; Ehab Badran; Amal Fathy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-01-30       Impact factor: 3.944

10.  Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review.

Authors:  Judith R Glynn; Jennifer Whiteley; Pablo J Bifani; Kristin Kremer; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2002-08       Impact factor: 6.883

View more
  1 in total

1.  Novel mutations detected from drug resistant Mycobacterium tuberculosis isolated from North East of Thailand.

Authors:  Ei Phoo Thwe; Wises Namwat; Porntip Pinlaor; Kulrattana Rueangsak; Arunnee Sangka
Journal:  World J Microbiol Biotechnol       Date:  2021-10-13       Impact factor: 3.312

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.